Articles about Biotech – Page 5 of 8

Seattle Genetics beats earnings expectations as lead drug Adcetris finds market success

Seattle Genetics, the maker of cancer drug Adcetris, beat analyst expectations by a noticeable margin in its third-quarter earnings, reported… Read More

Seattle Children’s licenses gene-editing therapy to Casebia Therapeutics and will partner on further research

The Seattle Children’s Research Institute announced Wednesday that it has licensed a new gene therapy technology to Cambridge, Mass.,-based biotech company… Read More

Stephen Hawking, take heart: Revalesio’s ALS drug gets regulatory boost from FDA

Revalesio, a biomedical company headquartered in Tacoma, Wash., says it’s been cleared to benefit from federal incentives for the development… Read More

Fred Hutch licenses new immunotherapy treatment to Mustang Bio, preps clinical trials in Seattle

A new immunotherapy technology developed at Seattle’s Fred Hutchinson Cancer Research Center has been licensed to New York-based Mustang Bio,… Read More

Cardiac Insight raises $4.5M to speed up sales and production of wearable ECG heartbeat sensor

Kirkland, Wash.-based startup Cardiac Insight has raised an additional $4.5 million to bolster production and distribution of its lightweight disposable… Read More

Podcast

Week in Geek Podcast: Uber’s CEO surprise, a milestone in the fight against cancer, and more

It was an unusually busy week for news in the world of business, technology and science. Join us on this… Read More

New ‘hit-and-run’ gene editing tool temporarily rewrites genetics to treat cancer and HIV

CAR T immunotherapies are all the rage in the medical community, reprogramming a patient’s immune system to fight cancer. For… Read More

Juno Therapeutics stock jumps 40% as rival Kite Pharma reaches deal to be acquired for $11.9B

Seattle’s Juno Therapeutics, a biotech company developing cutting edge CAR T immunotherapies for cancer, faces a narrow field of competitors. Few… Read More

Why Seattle’s Omeros continues to be dogged by questions over its next big drug

Omeros, one of Seattle’s biggest biotech companies, may have its hands on a lucrative new drug — but questions about… Read More

Omeros looks to raise $70M in stock offering to fuel drug development pipeline

The Omeros Corporation, one of Seattle’s biggest biotech companies, is looking to raise approximately $70 million in a follow-on public… Read More

Juno Therapeutics posts mixed results, remains optimistic about treatment pipeline

Seattle-based biotech company Juno Therapeutics beat analyst expectations in its second quarter revenue Thursday, reporting $21.3 million in revenue for… Read More

Cyrus Biotech raises $8M to boost protein modeling toolkit for drug discovery

Cyrus Biotechnology is getting an $8 million infusion for its cloud-based protein modeling and design toolkit, thanks to a Series… Read More

A secret Amazon team is reportedly working on disruptive healthcare tech

Amazon is on a mission to disrupt everything from retail to data storage to entertainment media, so it should come… Read More

Regenerative medicine startup Rodeo Therapeutics raises $5.9M for drugs to regenerate tissue

If you could write a medical wish-list of futuristic technologies, regenerating tissue would be pretty high up there. It could… Read More

Seattle startup raises $12M to ‘rewrite the software of life’ (with a little help from the technology behind beer)

Proteins are incredibly important, but incredibly complicated, molecules. They control 98 percent of all biological functions and are used in industries… Read More

New breed of microbrew: UW chemists use 3-D printing to blaze a trail for better beer

Long before you take that first sip of an ice-cold beer, the ingredients that went into that beverage had to… Read More

Agriculture startup raises $7M to grow apples, cherries, and nuts in high-tech gel

Phytelligence is raising more cash to further develop its technology that helps grow food crops like apples, cherries, hops, and… Read More

Biomedical labs at UW and in Boston win $10M grants from Allen Frontiers Group

The Paul G. Allen Frontiers Group, created by Microsoft co-founder Paul Allen to speed the pace of biomedical breakthroughs, is… Read More

Hemex Health lands $1.7M for lab-in-a-box that diagnoses malaria and sickle cell disease

We often think about global health as a philanthropic endeavor, something addressed by nonprofits and NGOs. But there is a… Read More

Biotech startup Aortica raising $4M to develop personalized blood vessel stents for aortic aneurysms

The aorta is an important blood vessel, to say the least. It’s the body’s main artery, carrying blood from the heart… Read More

Star Trek’s Tricorder, realized? This device uses AI to diagnose medical conditions

According to Star Trek, 23rd century doctors will diagnose most illnesses and determine the general state of health via a… Read More

Chinese genomics giant BGI announces West Coast Innovation Center to fuel international collaboration

Seattle’s history in genomics is long and storied. It’s home to organizations including the University of Washington, genomics pioneer Dr.… Read More

Startup Spotlight: Phoresa is creating a ‘pregnancy-style’ test for infectious diseases

Pregnancy tests, even those done in hospitals or clinics, are very straightforward. Some urine plus a detector and you have… Read More

Genoa Pharmaceuticals raises $62M for clinical trials and names Bruce Montgomery CEO

Genoa Pharmaceuticals — a biopharmaceutical company working on treatments for respiratory diseases — was operating under the radar just last week.… Read More

Juno Therapeutics’ revenue surges on Celgene partnership, loss increases on R&D spending

Seattle-based biotech juggernaut Juno Therapeutics delivered mixed results in its 2017 quarter one earnings report Thursday — the first financial report… Read More

Startup Spotlight: This biotech company uses fermentation to produce custom compounds

Here’s a wacky concept. Imagine you could give a microorganism, like yeast, specific instructions on what to produce during fermentation.… Read More

Geek of the Week: CIDR president John Aitchison could have been a pro sailor, but chose to cure deadly diseases instead

John Aitchison is a man of many talents. “Growing up, I wanted to be a professional sailor, but that seemed… Read More

Alpine Immune Sciences raising $17M in advance of merger with Colorado pharmaceutical company

Seattle biotech company Alpine Immune Sciences is raising $17 million as part of a merger with Nivalis, a publicly-traded pharmaceutical firm… Read More

Fred Hutch study: New nanoparticle immunotherapy could replace chemo as front-line cancer treatment

Dr. Matthias Stephan has a vision: cancer-killing immunotherapy that is so cheap and easy to access it replaces chemotherapy as the… Read More

M3 Biotechnology gets another $1.4M in funding, prepares to start clinical trials of leading drug candidate

Seattle-based M3 Biotechnology announced it has received a $1.4 million investment from the Alzheimer’s Drug Discovery Foundation, allowing it to begin… Read More